EICHOR
● Not Yet Recruiting
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
Condition: SARS-CoV-2 · Sponsor: Shionogi
About this study
The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized adult and adolescent participants with COVID-19 who are at high risk for progression to severe disease.
This description comes directly from the study's public registry record.
Talk to the study team
Shionogi Clinical Trials Administrator Clinical Support Help Line · 1-800-849-9707 · Shionogiclintrials-admin@shionogi.co.jp
Always discuss trial participation with your own doctor first.
Locations (27)
| Hope Clinical Trials - 3970 W Flagler St. | Coral Gables, Florida, United States | — |
| Continental Clinical Research, LLC | Miami, Florida, United States | — |
| Reed Medical Research | Miami, Florida, United States | — |
| Kendall South Medical Center Inc. | Miami, Florida, United States | — |
| Global Clinical Professionals | St. Petersburg, Florida, United States | — |
| New Tampa Health | Tampa, Florida, United States | — |
| Research Bay, Inc. | Tampa, Florida, United States | — |
| Hometown Urgent Care and Research | Cincinnati, Ohio, United States | — |
| Medical Center Unimed EOOD | Sevlievo, Gabrovo, Bulgaria | — |
| Medichi Sofia - Medical Center OOD | Sofia, Sofia, Bulgaria | — |
| MCpulmo-2018 Ltd | Haskovo, Bulgaria | — |
| Medical Center Medconsult Pleven - Lovech Branch | Lovech, Bulgaria | — |
+ 15 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07743580